Showing results (11-20 of 24) with videos related to
Sort By:
Pageof 3
Biochemical Pharmacology|September 15, 1986
Effects of the chrysotherapeutic agents auranofin and gold sodium thiomalate on hepatic and renal drug metabolism and heme metabolismT B Leonard, M E Graichen, L J Dahm, et al.Carcinogenesis|January 1, 1982
Comparison of hepatic carcinogen initiation-promotion systemsT B Leonard, J G Dent, M E Graichen, et al.Toxicology and Applied Pharmacology|December 16, 1998
Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasiaD C Kossor, P C Meunier, D M Dulik, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1985
Effects of methapyrilene on rat hepatic xenobiotic metabolizing enzymes and liver morphologyM E Graichen, D A Neptun, J G Dent, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1989
Methoxyflurane enhances allyl alcohol hepatotoxicity in rats. Possible involvement of increased acrolein formationW C Kershaw, D A Barsotti, T B Leonard, et al.The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Inhibition by ranitidine of acetaminophen conjugation and its possible role in ranitidine potentiation of acetaminophen-induced hepatotoxicityS A Rogers, K C Gale, J F Newton, et al.Archives of Biochemistry and Biophysics|December 1, 1988
Peroxidation-dependent and peroxidation-independent mechanisms by which acetaminophen kills cultured rat hepatocytesJ L Farber, T B Leonard, M E Kyle, et al.American Journal of Respiratory Cell and Molecular Biology|September 9, 1998
Effects of LTD4 on human airway smooth muscle cell proliferation, matrix expression, and contraction In vitro: differential sensitivity to cysteinyl leukotriene receptor antagonistsR A Panettieri, E M Tan, V Ciocca, et al.Biochemical Pharmacology|December 3, 1993
Cholestatic potentials of alpha-naphthylisothiocyanate (ANIT) and beta-naphthylisothiocyanate (BNIT) in the isolated perfused rat liverD C Kossor, J A Handler, D M Dulik, et al.Lancet (London, England)|November 3, 1998
Randomised, dose-ranging, placebo-controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthmaO M Kon, B S Sihra, C H Compton, et al.Pageof 3